Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis

• Published in: Reproduction (Cambridge, England) Vol. 133; no. 4; pp. 719 - 731
• Main Authors: Chabrolle, Christine, Tosca, Lucie, Dupont, Joélle
• Format: Journal Article
• Language: English
• Published: England Society for Reproduction and Fertility 01.04.2007; BioScientifica Ltd
• Subjects: Adiponectin - genetics; Adiponectin - metabolism; Adiponectin - pharmacology; Animals; Blotting, Western - methods; Cell Line; Chorionic Gonadotropin - pharmacology; Estradiol - biosynthesis; Female; Granulosa Cells - drug effects; Granulosa Cells - metabolism; Humans; Immunohistochemistry; Insulin-Like Growth Factor I - pharmacology; Mitogen-Activated Protein Kinase Kinases - metabolism; Ovary - drug effects; Ovary - metabolism; p38 Mitogen-Activated Protein Kinases - metabolism; Phosphorylation; Progesterone - biosynthesis; Proto-Oncogene Proteins c-akt - metabolism; Rats; Receptor, IGF Type 1 - metabolism; Receptors, Adiponectin; Receptors, Cell Surface - analysis; Receptors, Cell Surface - genetics; Receptors, Cell Surface - metabolism; Recombinant Proteins - pharmacology; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - analysis; Stimulation, Chemical
• ISSN: 1470-1626; 1741-7899
• DOI: 10.1530/REP-06-0244

In mammals, adiponectin and its receptors (AdipoR1 and AdipoR2) mRNAs are expressed in various tissues. However, the cellular expression and the role of adiponectin system have never been investigated in rat ovary. Here, we report the presence of adiponectin, AdipoR1 and AdipoR2 in rat ovaries, and we have investigated its role in granulosa cells. Using RT-PCR and western blot, we show that the mRNAs and proteins for adiponectin, AdipoR1 and AdipoR2 are found in the ovaries. Immunohistochemistry localized adiponectin, AdipoR1 and AdipoR2 in theca-interstitial T-I cells, corpus luteum, oocyte and less abundantly in granulosa cells. In the KGN human granulosa cell line, adiponectin mRNA and protein were undetectable; AdipoR2 was weakly expressed, whereas AdipoR1 was clearly present. Human chorionic gonadotrophin (hCG) injection (48 h) after pregnant mare serum gonadotrophin (PMSG) injection (24 h) in immature rats increased the level of adiponectin (protein) by about threefold (P < 0.05) and those of AdipoR1 by threefold (mRNA, P < 0.05) and 1.5-fold (protein, P < 0.05) in ovary, whereas the mRNA and protein levels of AdipoR2 were unchanged. Interestingly, hCG injection (48 h) after the PMSG treatment (24 h) decreased plasma adiponectin levels and increased insulin plasma levels. In vitro in primary rat granulosa cells, human adiponectin recombinant (5 μg/ml) in the presence or absence of follicle-stimulating hormone (10−8 M, 48 h) had no effect on the steroidogenesis. However, it increased progesterone secretion (P < 0.05) by about twofold and oestradiol production (P < 0.05) by about 1.6-fold in response to insulin-like growth factor-I (IGF-I) (10−8 M). Furthermore, it improved IGF-I-induced IGF-I receptor-β subunit tyrosine phosphorylation and ERK1/2 phosphorylation. In basal state, human adiponectin recombinant also increased rapidly but transiently the ERK1/2, p38 and Akt phosphorylations, whereas it increased more lately the adenosine 5′-monophosphate-activated protein kinase (AMPK) phosphorylation. Thus, AdipoR1 and AdipoR2 are regulated by hCG treatment in rat ovary and adiponectin enhances IGF-I-induced steroidogenesis in granulosa cells.